Imatinib - Wikipedia
Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial - The Lancet Haematology
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment - Clinical Lymphoma, Myeloma and Leukemia
Comparative results from frontline randomized clinical trials of... | Download Table
Imatinib in the treatment of chronic myeloid leukemia: current perspec | BLCTT
A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease | Leukemia
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (
Summary of selected randomized clinical trials evaluating high-dose... | Download Table
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial - The Lancet Oncology
Clinical trial of imatinib (Gleevec) in ovarian cancer | Download Table
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years | European Respiratory Society
Summary of clinical trials where imatinib mesylate (Gleevec, Novartis)... | Download Table
GLIVEC® (imatinib) in Newly Metastatic KIT+ GIST
Imatinib as the first‐line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials? - Zackova - 2011 -
Imatinib ongoing clinical trials. | Download Scientific Diagram
GLEEVEC® (imatinib mesylate) | KIT + GIST & Ph+ CML
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial - The Lancet Respiratory Medicine
Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials | Haematologica
Gastrointestinal Stromal Tumors: Management of Advanced Disease | MDedge Hematology and Oncology
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia | NEJM
Effect of imatinib alone or in combination in melanoma clinical trials. | Download Scientific Diagram
Clinical trials of imatinib | Download Table
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia | NEJM
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia | NEJM
